PolyPid Historical Balance Sheet
| PYPD Stock | USD 2.87 0.05 1.77% |
Trend analysis of PolyPid balance sheet accounts such as Net Debt of 6.5 M, Accounts Payable of 1.3 M, Cash of 5.8 M or Non Current Assets Total of 7.8 M provides information on PolyPid's total assets, liabilities, and equity, which is the actual value of PolyPid to its prevalent stockholders. By breaking down trends over time using PolyPid balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining PolyPid latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PolyPid is a good buy for the upcoming year.
PolyPid Inventory |
|
PolyPid |
About PolyPid Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of PolyPid at a specified time, usually calculated after every quarter, six months, or one year. PolyPid Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PolyPid and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PolyPid currently owns. An asset can also be divided into two categories, current and non-current.
PolyPid Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of PolyPid assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PolyPid books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on PolyPid balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PolyPid are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from PolyPid's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PolyPid current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.At present, PolyPid's Net Debt is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 1.3 M, whereas Total Current Liabilities is forecasted to decline to about 4 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 3.9M | 1.5M | 2.0M | 1.7M | Total Assets | 44.2M | 26.0M | 15.4M | 25.8M |
PolyPid balance sheet Correlations
Click cells to compare fundamentals
PolyPid Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PolyPid balance sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Other Current Liab | 998K | 1.9M | 3.9M | 1.5M | 2.0M | 1.7M | |
| Total Current Liabilities | 2.6M | 2.9M | 7.8M | 8.6M | 7.3M | 4.0M | |
| Total Stockholder Equity | 30.9M | 72.8M | 36.2M | 5.9M | (2.1M) | (2.2M) | |
| Property Plant And Equipment Net | 6.1M | 5.9M | 8.8M | 11.7M | 9.2M | 5.3M | |
| Net Debt | (3.9M) | (4.3M) | (9.8M) | 5.2M | 6.2M | 6.5M | |
| Retained Earnings | (93.3M) | (132.3M) | (174.6M) | (214.4M) | (238.3M) | (226.4M) | |
| Accounts Payable | 1.6M | 974K | 4.1M | 1.1M | 772K | 1.3M | |
| Cash | 3.9M | 4.3M | 9.8M | 8.6M | 5.6M | 5.8M | |
| Non Current Assets Total | 6.4M | 28.3M | 9.4M | 11.8M | 9.3M | 7.8M | |
| Non Currrent Assets Other | 31K | 22.2M | 423K | 99K | 87K | 82.7K | |
| Other Assets | 230K | 22.8M | 663K | 99K | 113.9K | 108.2K | |
| Cash And Short Term Investments | 26.6M | 44.5M | 32.2M | 12.6M | 5.6M | 5.3M | |
| Net Receivables | 42K | (251K) | 118K | (213K) | (191.7K) | (182.1K) | |
| Liabilities And Stockholders Equity | 33.8M | 75.8M | 44.2M | 26.0M | 15.4M | 25.8M | |
| Non Current Liabilities Total | 251K | 193K | 199K | 11.5M | 10.2M | 9.7M | |
| Other Current Assets | 399K | 2.3M | 2.2M | 1.1M | 458K | 878.4K | |
| Other Stockholder Equity | 124.2M | 205.1M | 210.8M | 220.3M | 236.2M | 248.0M | |
| Total Liab | 2.8M | 3.1M | 8.0M | 20.1M | 17.5M | 24.1M | |
| Total Current Assets | 27.4M | 47.6M | 34.8M | 14.2M | 6.1M | 5.8M | |
| Accumulated Other Comprehensive Income | (766K) | (1.2M) | (106.4M) | (3.1M) | (2.8M) | (3.0M) | |
| Property Plant Equipment | 6.1M | 5.9M | 8.8M | 11.7M | 13.4M | 14.1M | |
| Other Liab | 251K | 193K | 199K | 2.8M | 3.3M | 3.4M | |
| Net Tangible Assets | (87.6M) | 72.8M | 36.2M | 5.8M | 6.7M | 7.0M | |
| Short Term Investments | 14.0M | 0.0 | 22.7M | 40.2M | 22.4M | 4.0M | |
| Non Current Liabilities Other | 251K | 193K | 199K | 174K | 398K | 273.2K | |
| Net Invested Capital | 30.9M | 72.8M | 36.2M | 17.5M | 8.3M | 8.7M | |
| Net Working Capital | 24.8M | 44.3M | 27.0M | 5.6M | (1.2M) | (1.2M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PolyPid is a strong investment it is important to analyze PolyPid's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PolyPid's future performance. For an informed investment choice regarding PolyPid Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.22) | Return On Assets (0.65) | Return On Equity (4.97) |
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.